Kameel D. Farag - 05 Jan 2026 Form 4 Insider Report for BIOVIE INC. (BIVI)

Role: Director
Signature: /s/ Joanne Wendy Kim, attorney-in-fact for Kameel Farag
Issuer symbol: BIVI
Transactions as of: 05 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 09 Jan 2026, 17:01:17 UTC
Previous filing: 18 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Farag Kameel D.	Director	C/O BIOVIE INC., 680 W NYE LANE STE. 201, CARSON CITY	/s/ Joanne Wendy Kim, attorney-in-fact for Kameel Farag	09 Jan 2026	0002093620

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIVI	Stock Option (right to buy)	Award	$0	+57,500		$0.000000	57,500	05 Jan 2026	COMMON STOCK	57,500	$1.31	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	7,500 shares of the underlying options vest s on grant date and the remaining balance in four equal installments on February 11, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting.